Cellyan Biotechnology Co., Ltd
HKPD · XNASCIK 2007702fmd_1DHDQXTH0A4NWT65XKD54NGRRZWholesale Trade · Wholesale-Drugs, Proprietaries & Druggists' SundriesTemplate: Standard
Coverage: Apr 01, 2022 to Mar 31, 2026, 6 periods
| Line item | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total revenues | 13 | 17 | 20 |
| Cost of revenue | 10 | 13 | 18 |
| Gross profit | 3 | 4 | 2 |
| Selling, general and administrative | 2 | 2 | 2 |
| Operating income | (2) | (2) | (2) |
| Interest expense | 0 | 0 | 0 |
| Income before taxes | 1 | 2 | 0 |
| Income tax expense | 0 | 0 | 0 |
| Net income from continuing operations | 1 | 1 | (0) |
| Net income | 1 | 1 | (0) |
| Net income to common shareholders | 1 | 1 | (0) |